The Primary
Care Companionfor CNS Disorders

Schizophrenia/Schizoaffective Disorders

Original Research June 15, 2005

CME Article: The Relation Between Body Fat Distribution and Cardiovascular Risk Factors in Patients With Schizophrenia: A Cross-Sectional Pilot Study

Martha M. Lato, ; M. Beatriz Currier, ; Oscar Villaverde, ; Mercedes Gonzalez-Blanco,

Prim Care Companion J Clin Psychiatry 2005;7(3):115-118

Article Abstract

Schizophrenia Weight Cardiovascular Health

Author Affiliations

References (1)

Download Free PDF

Save

Cite

SPOTLIGHT

Balancing Psychiatric Stability and Cardiometabolic Health in Bipolar I Disorder
Dr Goldberg takes viewers through two case profiles of patients with bipolar I disorder, including assessment, diagnosis, and treatment, with a focus on cardiometabolic safety.

Related Articles

Clozapine Exposure and Risk of Hematologic Malignancies in Veterans with Schizophrenia

Clozapine Exposure and Risk of Hematologic Malignancies in Veterans with Schizophrenia

May 15, 2024

Clozapine exposure of at least 5 years was associated with hematologic malignancy, and the increased risk was dose-dependent.

Concomitant LAIs and Time to Rehospitalization in Patients Receiving Clozapine

Concomitant LAIs and Time to Rehospitalization in Patients Receiving Clozapine

May 1, 2024

Clozapine plus LAI antipsychotics was associated with lower risk of rehospitalization compared to both clozapine plus oral antipsychotics and clozapine monotherapy.

Clozapine Use and Specific Indications

Clozapine Use and Specific Indications

April 29, 2024

Clozapine initiation is uncommon in people with psychotic disorders who have experienced events suggesting clozapine is indicated, with even lower rates in Black and Hispanic patients.